Home > Insider Trading > Filing (0001209191-20-064574)

Filing Details

Accession Number:: 0001209191-20-064574
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-12-18 20:29:01
Reporting Period:: 2020-12-16

Accepted Time:: 2020-12-18 20:29:01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1808158	Repare Therapeutics Inc.	RPTX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1815366	Michael Zinda	C/O Repare Therapeutics Inc. 7210 Frederick-Banting, Suite 100 St-Laurent A8 H4S 2A1	Evp, Chief Science Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-12-16	6,876	$1.64	92,105	No	4	M	Direct
Common Stock	Acquisiton	2020-12-16	2,080	$1.64	94,185	No	4	M	Direct
Common Stock	Disposition	2020-12-16	8,022	$35.17	86,163	No	4	S	Direct
Common Stock	Disposition	2020-12-16	934	$36.01	85,229	No	4	S	Direct
Common Stock	Acquisiton	2020-12-18	8,321	$2.06	93,550	No	4	M	Direct
Common Stock	Disposition	2020-12-18	8,121	$34.59	85,429	No	4	S	Direct
Common Stock	Disposition	2020-12-18	200	$35.10	85,229	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2020-12-16	6,876	$0.00	6,876	$1.64
Common Stock	Employee Stock Option (right to buy)	Disposition	2020-12-16	2,080	$0.00	2,080	$1.64
Common Stock	Employee Stock Option (right to buy)	Disposition	2020-12-18	8,321	$0.00	8,321	$2.06

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
4,122	2027-06-14	No	4	M	Direct
29,538	2027-12-04	No	4	M	Direct
85,707	2029-03-29	No	4	M	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to$35.753 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth infootnotes (1), (2), (3) and (4).
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.23 inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.02 to $34.99 inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.05 to $35.15 inclusive.
Twenty-five percent (25%) of the shares subject to the option vested on June 14, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.
Twenty-five percent (25%) of the shares subject to the option vested on June 22, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.
Twenty-five percent (25%) of the shares subject to the option vested on March 29, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.